ONCO · Oncopeptides AB

1.80

SEK

-0.524 (-22.547%)

14/10/2026 12:00:00 AM

Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

kr1.13B

0.00

EV/EBITDA

N/A

DIV Yield

0%

Payout Ratio

0%

MQV Rating

5Very Weak

As at 14/10/2026 12:00:00 AM

Price Chart

Description

Oncopeptides AB is a pharmaceutical company, which is involved in the development of targeted therapies for hematological diseases. The firm focuses on its product candidate melflufen, a peptide conjugated alkylator, belonging to a new class of drugs called peptidase enhanced cytotoxics, which targets aminopeptidases and rapidly releases alkylating agents into tumor cells. The company was founded by Rolf Larsson, Rolf Lewensohn, Joachim Gullbo, Kristina Luthman, Hans Ehrsson, and Peter Nygren on September 5, 2000 and is headquartered in Stockholm, Sweden.

All-Companies
All-Consensus
Big Candle
HALO 200
HALO All
HALO Balance Sheet
HALO Capital Efficiency
HALO Small
Near Resistance
Short Term Trend - Long
Volume Spike

Key Fundamentals

EPS 3 yr Growth

-60.10%

EBITDA Margin

-308.30%

Operating Cashflow

-kr223m

Free Cash Flow Return

-170.50%

ROIC

-190.90%

Interest Coverage

-15.20

Quick Ratio

2.40

Performance

52 weeks range

Low 1.25 - 5.79

Trade Value (12mth)

US$210,855.00

1 week

40.74%

1 month

80.73%

YTD

-35.56%

1 year

-41.93%

All time high

136.28

Additional Data

Shares Outstanding (Fully Diluted)

381m

HALO Sector

Healthcare

Next Company Report Date

18-Feb-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

SEK

Short Sell (% of issue)

0.00

Consensus

Unlock full consensus

Consensus score

/10

Recommendation

Buy

Target price

Deviation

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Very Strong

Event

Neutral

Halo Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Very Weak

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Neutral

Dividends

Very Weak

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

Valuation

Unlock full dataset

Value

Consensus

Yield

News & Announcements

No announcements available.

Key Stakeholders

Name	Title
HealthCap AB	Subsidiary
Avanza Bank Holding AB	Public Company
Nordnet AB	Public Company
Magnus Karlsson	Individual
Stig Anders Jakob Lindberg	Individual